Emanuel Boeminghaus wrote that Bayer intends to invest 2.2 billion dollars in a new production facility in the US state of Ohio. Around 600 highly qualified jobs were to be created in New Albany; pharmaceutical active ingredients and finished medicines were to be produced there in the future. Boeminghaus contrasted the investment with Germany's struggle for capital and industrial jobs, calling it another warning signal. According to its own statements, Bayer has already invested more than seven billion dollars in research, development, and production in the US within five years. Boeminghaus summarized his assessment with the words "They are fleeing!" and referred to Handelsblatt as the source. https://t.co/ZPz13szcSP #Bayer #Industrie #USA (translated)

